EUVIMEDEUVIMED entdecken
Studienprotokoll

Indian Trial of Tranexamic acid in Spontaneous Intracerebral Hemorrhage study protocol

Jeyaraj Durai Pandian iD, Atul Phillips, Shweta Jain Verma iD, Deepti Arora iD, Aneesh Dhasan, Pheba S Raju, P N Sylaja, Biman Kanti Ray, Uddalak Chakraborty, Jacob Johnson, Praveen Kumar Sharma, Sanjeev Bhoi und 48 weitere

International Journal of Stroke · 2025

DOI: 10.1177/17474930241307933 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift International Journal of Stroke, 2025. Verfasst von Jeyaraj Durai Pandian und 59 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Unit, Department of Neurology, Christian Medical College & Hospital, Ludhiana, Ludhiana, India. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Cerebral Hemorrhage, Tranexamic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Early mortality in intracerebral hemorrhage (ICH) is due to hematoma volume (HV) expansion, and there are no effective treatments available other than reduction in blood pressure. Tranexamic acid (TXA) a hemostatic drug that is widely available and safe can be a cost-effective treatment for ICH, if proven efficacious. Hypothesis: Administration of TXA in ICH patients when given within 4.5 h of symptom onset will reduce early mortality at 30 days.

Design

Indian Trial of Tranexamic acid in Spontaneous Intracerebral Haemorrhage (INTRINSIC trial) is a multicenter, randomized, open-label, trial enrolling patients aged more than 18 years presenting with non-traumatic ICH within 4.5 h of symptom onset or when last seen well. Study participants received 2 g of TXA administered within 45 min while control group received standard of care. Intensive blood pressure reduction as per INTERACT 2 protocol is followed is done in both groups. Study plans to recruit 3400 patients. Primary outcome is mortality at day 30. Secondary outcomes are radiological reduction in HV at 24 h from baseline, neurological impairment at day 7 or earlier (if discharged), and assessments of dependency and quality of life at day 90. Summary: If proven to be beneficial, TXA will have a major impact on medical management of ICH.

Trial registration

Clinical Trial Registry India (CTRI/2023/03/050224) and Clinical Trials.gov (NCT05836831).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrinolytic AgentsCerebral HemorrhageTranexamic AcidFemaleHumansMaleMiddle AgedIndiaRandomized Controlled Trials as TopicTreatment OutcomeMulticenter Studies as Topic

Stichwörter der Autor:innen

Intracerebral hemorrhagehematomamanagementrandomized clinical trialtranexamic acidvolume

Substanzen

Antifibrinolytic AgentsTranexamic Acid

Autor:innen und Institutionen

  • Stroke Unit, Department of Neurology, Christian Medical College & Hospital, Ludhiana, Ludhiana, India.
  • Department of Neuro-critical Care, University of Calgary, Calgary, AB, Canada.
  • Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Thiruvananthapuram, India.
  • Department of Neurology, Bangur Institute of Neurology, Institute of Postgraduate Medical Education and Research, Kolkata, India.
  • Department of Medicine, Baptist Christian Hospital, Tezpur, India.
  • Department of Neurology, King George's Medical University, Lucknow, India.

ORCID-Profile: Jeyaraj Durai Pandian, Shweta Jain Verma, Deepti Arora, Jayanta Roy, Sanjith Aaron, Sankar Prasad Gorthi, Girish Baburao Kulkarni

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Pandian, J. D., Phillips, A., Verma, S. J., Arora, D., Dhasan, A., Raju, P. S., Sylaja, P. N., Ray, B. K., Chakraborty, U., Johnson, J., Sharma, P. K., Bhoi, S., Jha, M., Iype, T., P, C., Khurana, D., Ray, S., Das, D., Kalita, N., …, & Menon, D. (2025). Indian Trial of Tranexamic acid in Spontaneous Intracerebral Hemorrhage study protocol. International Journal of Stroke. https://doi.org/10.1177/17474930241307933

Vancouver

Pandian JD, Phillips A, Verma SJ, Arora D, Dhasan A, Raju PS, et al. Indian Trial of Tranexamic acid in Spontaneous Intracerebral Hemorrhage study protocol. International Journal of Stroke. 2025. doi:10.1177/17474930241307933

BibTeX
@article{Pandian2025,
  author = {Pandian, Jeyaraj Durai and Phillips, Atul and Verma, Shweta Jain and Arora, Deepti and Dhasan, Aneesh and Raju, Pheba S and Sylaja, P N and Ray, Biman Kanti and Chakraborty, Uddalak and Johnson, Jacob and Sharma, Praveen Kumar and Bhoi, Sanjeev and Jha, Menka and Iype, Thomas and P, Chithra and Khurana, Dheeraj and Ray, Sucharita and Das, Dwijen and Kalita, Naurima and Adhikari, Sweekriti and Sharma, Ashish and Roy, Jayanta and Sahonta, Rajeshwar and Singh, Sulena and Chaudhary, Vikram and Menon, Girish and Aaron, Sanjith and Bal, Deepti and Dhamija, Rajinder K and Chaturvedi, Monali and Maheshwari, Siddarth and Saroja, Aralikatte Onkarappa and Naik, Karkal R and Bhutani, Neeraj and Dhankhar, Kailash and Sharma, Dinesh and Bhatia, Rohit and Gorthi, Sankar Prasad and Sarmah, Binod and Pamidimukkala, Vijaya and Saravanan, Sankaralingam and Narayan, Sunil and Basumatary, Lakshya J and Sundarachary, Nagarjunakonda V and Upputuri, Aruna K and Karadan, Ummer and Pradeep Kumar, V G and Parthasarathy, Rajsrinivas and Doshi, Darshan and Wagh, Satish and Ramakrishnan, Tcr and Akhtar, Saleem and Desai, Soaham and Borah, N C and Das, Rupjyoti and Mittal, Gaurav and Jain, Agam and Alapatt, Paul J and Kulkarni, Girish Baburao and Menon, Deepak},
  title = {Indian Trial of Tranexamic acid in Spontaneous Intracerebral Hemorrhage study protocol},
  journal = {International Journal of Stroke},
  year = {2025},
  doi = {10.1177/17474930241307933}
}
Kostenlos starten →